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Background
Cardiac magnetic resonance (CMR) is the noninvasive
gold standard for evaluation of LV size/function due to
its low interscan/intraobserver/interobserver variability.
However, 2D echocardiography (Echo) remains the
modality of choice to assess LV function due to ease of
use, cost-effectiveness and ubiquity despite its known
higher method variability. Randomized trials showed
that automated implantable cardiac defibrillators (AICD)
provide survival benefit in ischemic/nonischemic cardio-
myopathy patients with LV ejection fraction (EF) ≤35%.
It is therefore important to correctly classify patients by
LVEF≤35% status to avoid improper placement or with-
holding of placement of AICD. We aim to quantify the
misclassification of LVEF≤35% by Echo when compared
to CMR in ischemic cardiomyopathy patients.
Methods
Ischemic cardiomyopathy (LVEF<40%) patients had car-
diac imaging at baseline and following 6 months of
micronutrient supplementation on top of optimal medi-
cal therapy as part of a dietary supplementation study.
Sixteen sets of same-day CMR and Echo scans were
compared (from 8 subjects, all males, 71±8 years). LVEF
was measured in CMR using cardiac-gated steady state
free precession gradient echo cine and modified Simp-
son’s method, while biplane volumetric method was
used in Echo. Correlation, ROC curve and kappa ana-
lyses were used.
Results
LVEF was 30.7±9.4% (CMR) and 28.3±9.0% (Echo)
(R=0.93, p<0.0001). CMR classified 10/16 while Echo
classified 10/16 as having LVEF≤35%. Using CMR as
gold standard, Echo misclassified 2 (12.5%) as having
LVEF≤35% and misclassified 1 (6.2%) as having
LVEF>35%. Kappa statistic for CMR and echo for
LVEF≤35% is 0.59, denoting moderate classification
agreement. By ROC analysis, an echo EF cutoff of 29%
has 80% sensitivity, 100% specificity for detecting CMR
LVEF≤35% with AUC of 0.92 (95%CI 0.67-0.99,
p=0.001, see figure).
Conclusions
Despite high correlation, Echo misclassified LVEF≤35%
in 18.75% of cardiomyopathy cases versus CMR. With
1.2 million MI patients per year in the US and published
data of 11% of MI patients having LVEF≤35% 90-days
after MI, 132,000 patients potentially require AICD
annually. Misclassification of LVEF≤35% by Echo has
substantial implications for delivery or withholding of
AICD therapy and the prognostic implications need to
be formally studied. Short of using CMR in all post-MI
patients, based on ROC analysis the misclassification
can potentially be minimized by measuring CMR LVEF
in patients with Echo EF≥30-40%.
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Figure 1 ROC curve analysis of Echo EF predicting CMR EF≤35%.
Echo EF≤29% has 80% sensitivity and 100% specificity for predicting
CMR EF≤35%.
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